Cambridge Isotope Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- Cambridge Isotope Laboratories's estimated annual revenue is currently $35M per year.
- Cambridge Isotope Laboratories's estimated revenue per employee is $105,105
Employee Data
- Cambridge Isotope Laboratories has 333 Employees.
- Cambridge Isotope Laboratories grew their employee count by 8% last year.
Cambridge Isotope Laboratories's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales and Marketing | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP, Information Technology | Reveal Email/Phone |
5 | VP Operations | Reveal Email/Phone |
6 | VP Finance | Reveal Email/Phone |
7 | VP Operations | Reveal Email/Phone |
8 | Director Analytical Chemistry | Reveal Email/Phone |
9 | Director Human Resources | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Cambridge Isotope Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $300M | 1809 | N/A | N/A | N/A |
What Is Cambridge Isotope Laboratories?
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the separation and manufacture of stable isotopes and stable isotope-labeled compounds. With over 400 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute a common atom for a rare, highly valued isotopic component so that the final product can be readily measured or traced using mass spectrometry (mass spec) or nuclear magnetic resonance (NMR). CIL¹s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide. We are proud that CIL products have contributed to medical advancements in cancer research, new drug development, environmental analysis, genomics and proteomics and medical diagnostic research. CIL¹s vision began when it was founded in 1981 by Dr. Joel Bradley, an organic chemist from MIT. We now produce more than 15,000 products and have ISO 13485 quality systems, as well as cGMP production capabilities. The CIL group is comprised of six companies: Cambridge Isotope Laboratories, Inc. (CIL), CIL Isotope Separations (CIS) and Membrane Receptor Technologies (MRT) in the US; CIL Canada, Inc. in Montreal, Canada; Euriso-Top in Saclay, France; and ABX GmbH in Dresden, Germany.
keywords:Biotechnology,Healthcare,Medical Diagnostics,PharmaceuticalsN/A
Total Funding
333
Number of Employees
$35M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cambridge Isotope Laboratories News
Cambridge Isotope Laboratories; Sigma-Aldrich; Thermo Fisher Scientific; LGC Standards; Toronto Research Chemicals; IsoLife BV; WITEGA Laboratorien; Omicron...
Stable Isotope Labeled Biomolecules Market Size 2022-2029| Key Players Cambridge Isotope Laboratories, Sigma-aldrich, Thermo Fisher Scientific, Lgc Standards.
Stable Isotope Labeled Compounds Market Size, Outlook And Forecast | Cambridge Isotope Laboratories, Merck KGaA, Urenco Limited, Isosciences, Medical Isotopes,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $240.5M | 541 | -3% | $357.5M |
#2 | $185.7M | 592 | 8% | N/A |
#3 | $122.7M | 677 | N/A | N/A |
#4 | $35M | 1031 | 0% | N/A |